The rise in antimicrobial resistance: An obscure issue in COVID-19 treatment

Yogendra Shrestha1, Ravi Kurikempannadoddi Shivalingegowda2, Melkote Jyotiprakash Avinash3

  • 1Department of Pharmacy Practice, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B. G. Nagara, India.

Insights

During pandemics, broad-spectrum antibiotics were overused in COVID-19 patients, leading to excessive quantities and reduced effectiveness against bacterial infections. This highlights a critical need for better antimicrobial stewardship and evidence-based treatments.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Pandemics strain healthcare systems, often leading to suboptimal prescribing of antibiotics.
  • Lack of evidence-based antivirals and poor antimicrobial stewardship contribute to broad-spectrum antibiotic overuse.
  • COVID-19 pandemic exacerbated these issues, prompting investigation into antibiotic use in infected patients.

Purpose of the Study:

  • To investigate antibiotic prescribing patterns in COVID-19 patients.
  • To assess the impact of these practices on antimicrobial resistance.
  • To evaluate the sensitivity of prescribed antibiotics against isolated bacterial pathogens.

Main Methods:

  • Prospective, cross-sectional study design.
  • Inclusion of 318 COVID-19 patients.
  • Antibiotic susceptibility testing using the disc diffusion method on 95 patient samples.

Main Results:

  • Antibiotics were prescribed in over 90% of all COVID-19 severity cases.
  • Bacterial growth confirmed in 58.95% of cultured samples, with E. coli being the most common.
  • Over 54.9% of detected antibiotics showed less than 50% sensitivity against the isolated bacteria.

Conclusions:

  • Antibiotics were frequently overprescribed in COVID-19 patients, irrespective of disease severity.
  • High rates of antibiotic use correlated with reduced sensitivity to common bacterial pathogens like E. coli.
  • Urgent need for improved antimicrobial stewardship and evidence-based treatment guidelines during pandemics to combat rising antimicrobial resistance.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
53
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
102
Antibiotic Selection00:57

Antibiotic Selection

Overview
54.9K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
482
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
409
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K